The store will not work correctly when cookies are disabled.
(2-(1H-pyrrol-1-yl)pyridin-4-yl)methanamine
ID: ALA4548179
PubChem CID: 84062116
Max Phase: Preclinical
Molecular Formula: C10H11N3
Molecular Weight: 173.22
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: NCc1ccnc(-n2cccc2)c1
Standard InChI: InChI=1S/C10H11N3/c11-8-9-3-4-12-10(7-9)13-5-1-2-6-13/h1-7H,8,11H2
Standard InChI Key: BHZZGCHGADJYMD-UHFFFAOYSA-N
Molfile:
RDKit 2D
13 14 0 0 0 0 0 0 0 0999 V2000
17.5682 -4.9898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5671 -5.8093 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.2751 -6.2183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9848 -5.8088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9819 -4.9862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2733 -4.5809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6881 -4.5749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3973 -4.9808 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.2709 -7.0325 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.6086 -7.5119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8611 -8.2900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6794 -8.2889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9299 -7.5101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
10 11 2 0
9 10 1 0
11 12 1 0
12 13 2 0
13 9 1 0
3 9 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 173.22 | Molecular Weight (Monoisotopic): 173.0953 | AlogP: 1.33 | #Rotatable Bonds: 2 |
Polar Surface Area: 43.84 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.11 | CX LogP: 1.44 | CX LogD: -0.26 |
Aromatic Rings: 2 | Heavy Atoms: 13 | QED Weighted: 0.74 | Np Likeness Score: -1.69 |
References
1. (2017) Ash1l inhibitors and methods of treatment therewith, |